谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

2096 Phase II trial of Irinotecan plus S-1 (IRIS) with Cetuximab (IRIS/Cet) in pre-treated patients with KRAS wild type of metastatic colorectal cancer (mCRC): HGCSG0902 updated analysis

M. Nakamura,Satoshi Yuki,H. Nakatsumi,O. Muto,A. Hosokawa, T. Kato,I. Iwanaga,K. Hatanaka,Y. Tsuji,A. Sato,K. Eto,K. Furukawa,H. Okuda,M. Onodera,K. Fujikawa,M. Kudo, S. Yokoyama,T. Honda,Y. Sakata,Yoshito Komatsu

EUROPEAN JOURNAL OF CANCER（2015）

引用 0|浏览17
暂无评分
关键词
metastatic colorectal cancer,colorectal cancer,irinotecan,cetuximab,pre-treated
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要